{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T13:15:22Z","timestamp":1780406122527,"version":"3.54.1"},"reference-count":91,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Prostaglandins (PGs) are eicosanoid compounds with various hormone-like effects within the human body. Prostaglandin D2 (PGD2), prostaglandin J2 (PGJ2, a metabolite of PGD2), and prostaglandin E2 (PGE2) are common prostaglandins. They are produced from arachidonic acid by cyclooxygenase isoenzymes (COX-1 and COX-2) and PG synthases and are involved in many biological metabolisms, including the inflammatory response. Recent studies show PGs are mediators for both proinflammatory and anti-inflammatory processes. In systemic lupus erythematosus (SLE), inflammation caused by autoimmunity damages tissues, leading to organ diseases such as lupus nephritis and lupus myocarditis. However, the roles of different types of PGs in the pathogenesis of SLE remain unclear. In this review, we discuss three types of PGs\u2014PGD2, PGJ2, and PGE2\u2014for their potential roles in SLE pathogenesis.<\/jats:p>","DOI":"10.3390\/ijms27114921","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T12:45:08Z","timestamp":1780404308000},"page":"4921","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Potential Roles of Prostaglandins PGD2, PGJ2, and PGE2 in the Pathogenesis of Systemic Lupus Erythematosus"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-6859-9491","authenticated-orcid":false,"given":"Tian","family":"Xu","sequence":"first","affiliation":[{"name":"Department of Biomedical Sciences and Pathobiology, College of Veterinary Medicine, Virginia Tech, Blacksburg, VA 24061, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2809-5836","authenticated-orcid":false,"given":"Xin M.","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences and Pathobiology, College of Veterinary Medicine, Virginia Tech, Blacksburg, VA 24061, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1056\/NEJMra1100359","article-title":"Systemic Lupus Erythematosus","volume":"365","author":"Tsokos","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"4843","DOI":"10.1113\/jphysiol.2008.154096","article-title":"Regulation of Smooth Muscle Contractility by the Epithelium in Rat Vas Deferens: Role of ATP-induced Release of PGE2","volume":"586","author":"Ruan","year":"2008","journal-title":"J. Physiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"8138","DOI":"10.4049\/jimmunol.178.12.8138","article-title":"The Proinflammatory Effect of Prostaglandin E2 in Experimental Inflammatory Bowel Disease Is Mediated through the IL-23\u2192IL-17 Axis","volume":"178","author":"Sheibanie","year":"2007","journal-title":"J. Immunol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1126\/science.287.5460.2013","article-title":"Prostaglandin D2 as a Mediator of Allergic Asthma","volume":"287","author":"Matsuoka","year":"2000","journal-title":"Science"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1002\/stem.1191","article-title":"Human Mesenchymal Stem\/Stromal Cells Cultured as Spheroids Are Self-activated to Produce Prostaglandin E2 That Directs Stimulated Macrophages into an Anti-inflammatory Phenotype","volume":"30","author":"Bartosh","year":"2012","journal-title":"Stem Cells"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.4049\/jimmunol.1401611","article-title":"The Cyclopentenone Prostaglandin 15d-PGJ2 Inhibits the NLRP1 and NLRP3 Inflammasomes","volume":"194","author":"Maier","year":"2015","journal-title":"J. Immunol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0304-4165(64)90145-X","article-title":"The Enzymatic Formation of Prostaglandin E2 from Arachidonic Acid Prostaglandins and Related Factors 32","volume":"90","author":"Danielsson","year":"1964","journal-title":"Biochim. Biophys. Acta BBA-Gen. Subj."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"15451","DOI":"10.1021\/bi026938h","article-title":"The Cyclooxygenase Reaction Mechanism","volume":"41","author":"Tsai","year":"2002","journal-title":"Biochemistry"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"G1147","DOI":"10.1152\/ajpgi.00184.2002","article-title":"Coordinated Regulation of Gastric Chloride Secretion with Both Acid and Alkali Secretion","volume":"283","author":"Coskun","year":"2002","journal-title":"Am. J. Physiol.-Gastrointest. Liver Physiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S0015-0282(16)48081-7","article-title":"The Prostaglandin Inhibitor Effect of Antiinflammatory Drugs in the Therapy of Male Infertility","volume":"42","author":"Barkay","year":"1984","journal-title":"Fertil. Steril."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/j.jaci.2013.01.035","article-title":"Prostaglandin D2 Pathway Upregulation: Relation to Asthma Severity, Control, and TH2 Inflammation","volume":"131","author":"Fajt","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"19802","DOI":"10.1073\/pnas.1110011108","article-title":"Prostagladin D2 Is a Mast Cell-Derived Antiangiogenic Factor in Lung Carcinoma","volume":"108","author":"Murata","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1053\/j.gastro.2019.01.208","article-title":"29 Human Bone Marrow Derived Mesenchymal Stem Cells Mediate Immunosuppression in Experimental Crohn\u2019s Disease by Secreting Prostaglandin E2 and Reprogramming Macrophages to an Anti-Inflammatory Phenotype","volume":"156","author":"Dave","year":"2019","journal-title":"Gastroenterology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.clim.2004.09.008","article-title":"15d-PGJ2: The Anti-Inflammatory Prostaglandin?","volume":"114","author":"Scher","year":"2005","journal-title":"Clin. Immunol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e031850","DOI":"10.1136\/bmjopen-2019-031850","article-title":"Association between Organ Damage and Mortality in Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis","volume":"10","author":"Lin","year":"2020","journal-title":"BMJ Open"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.smim.2006.12.005","article-title":"Regulation of Lupus-Related Autoantibody Production and Clinical Disease by Toll-like Receptors","volume":"19","author":"Christensen","year":"2007","journal-title":"Semin. Immunol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.1002\/art.11354","article-title":"B Lymphocyte Stimulator Overexpression in Patients with Systemic Lupus Erythematosus: Longitudinal Observations","volume":"48","author":"Stohl","year":"2003","journal-title":"Arthritis Rheum."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0888-7543(88)90003-1","article-title":"Regional Localization of the Interferon-\u03b22B-Cell Stimulatory Factor 2\/Hepatocyte Stimulating Factor Gene to Human Chromosome 7p15-P21","volume":"2","author":"Chen","year":"1988","journal-title":"Genomics"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/ni833","article-title":"B Cells Regulate Autoimmunity by Provision of IL-10","volume":"3","author":"Fillatreau","year":"2002","journal-title":"Nat. Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molimm.2020.11.010","article-title":"A Novel BAFF Antagonist, BAFF-Trap, Effectively Alleviates the Disease Progression of Systemic Lupus Erythematosus in MRL\/Lpr Mice","volume":"129","author":"Yu","year":"2021","journal-title":"Mol. Immunol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1093\/rheumatology\/kem097","article-title":"Expression of B-Cell Activating Factor of the Tumour Necrosis Factor Family (BAFF) in T Cells in Active Systemic Lupus Erythematosus: The Role of BAFF in T Cell-Dependent B Cell Pathogenic Autoantibody Production","volume":"46","author":"Morimoto","year":"2007","journal-title":"Rheumatology"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Accapezzato, D., Caccavale, R., Paroli, M.P., Gioia, C., Nguyen, B.L., Spadea, L., and Paroli, M. (2023). Advances in the Pathogenesis and Treatment of Systemic Lupus Erythematosus. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24076578"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1124\/pr.59.3.1","article-title":"Membrane Prostaglandin E Synthase-1: A Novel Therapeutic Target","volume":"59","author":"Samuelsson","year":"2007","journal-title":"Pharmacol. Rev."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"646","DOI":"10.5603\/FHC.2011.0088","article-title":"Imbalance between Th17 and Regulatory T-Cells in Systemic Lupus Erythematosus","volume":"49","author":"Kleczynska","year":"2012","journal-title":"Folia Histochem. Cytobiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2249.2009.03944.x","article-title":"Interleukin-17 and Systemic Lupus Erythematosus: Current Concepts","volume":"157","author":"Nalbandian","year":"2009","journal-title":"Clin. Exp. Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Katsuyama, T., Tsokos, G.C., and Moulton, V.R. (2018). Aberrant T Cell Signaling and Subsets in Systemic Lupus Erythematosus. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.01088"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/eji.201344280","article-title":"Regulatory T Cells in Systemic Lupus Erythematosus","volume":"45","author":"Ohl","year":"2015","journal-title":"Eur. J. Immunol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.cyto.2014.12.027","article-title":"Th1\/Th2\/Th17\/Treg Cytokine Imbalance in Systemic Lupus Erythematosus (SLE) Patients: Correlation with Disease Activity","volume":"72","author":"Talaat","year":"2015","journal-title":"Cytokine"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1002\/art.24499","article-title":"Th17 and Natural Treg Cell Population Dynamics in Systemic Lupus Erythematosus","volume":"60","author":"Yang","year":"2009","journal-title":"Arthritis Rheum."},{"key":"ref_30","first-page":"65","article-title":"Ratio of Th17\/Treg and Disease Activity in Systemic Lupus Erythematosus","volume":"10","author":"Yuliasih","year":"2019","journal-title":"Casp. J. Intern. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1084\/jem.20082293","article-title":"Prostaglandin E2 Regulates Th17 Cell Differentiation and Function through Cyclic AMP and EP2\/EP4 Receptor Signaling","volume":"206","author":"Boniface","year":"2009","journal-title":"J. Exp. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1172\/JCI72973","article-title":"Decreased RORC-Dependent Silencing of Prostaglandin Receptor EP2 Induces Autoimmune Th17 Cells","volume":"124","author":"Kofler","year":"2014","journal-title":"J. Clin. Investig."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1097\/BOR.0b013e328349a255","article-title":"Effector T-Cell Subsets in Systemic Lupus Erythematosus: Update Focusing on Th17 Cells","volume":"23","author":"Shin","year":"2011","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1186\/s12967-024-05450-x","article-title":"Re-Establishing Immune Tolerance in Multiple Sclerosis: Focusing on Novel Mechanisms of Mesenchymal Stem Cell Regulation of Th17\/Treg Balance","volume":"22","author":"Hu","year":"2024","journal-title":"J. Transl. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1182\/blood-2008-05-155408","article-title":"Prostaglandin E2 Synergistically with Interleukin-23 Favors Human Th17 Expansion","volume":"112","author":"Chizzolini","year":"2008","journal-title":"Blood"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nm.1968","article-title":"Prostaglandin E2\u2013EP4 Signaling Promotes Immune Inflammation through TH1 Cell Differentiation and TH17 Cell Expansion","volume":"15","author":"Yao","year":"2009","journal-title":"Nat. Med."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Mizui, M., and Tsokos, G.C. (2018). Targeting Regulatory T Cells to Treat Patients With Systemic Lupus Erythematosus. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.00786"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"100130","DOI":"10.1016\/j.jtauto.2021.100130","article-title":"Regulatory T Cell Function in Autoimmune Disease","volume":"4","author":"Rajendiran","year":"2021","journal-title":"J. Transl. Autoimmun."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jaut.2010.06.018","article-title":"Pathogenetic Aspects of Systemic Lupus Erythematosus with an Emphasis on Regulatory T Cells","volume":"35","author":"Scheinecker","year":"2010","journal-title":"J. Autoimmun."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"100090","DOI":"10.1016\/j.waojou.2019.100090","article-title":"Prostaglandin E2 Signal Inhibits T Regulatory Cell Differentiation during Allergic Rhinitis Inflammation through EP4 Receptor","volume":"12","author":"Li","year":"2019","journal-title":"World Allergy Organ. J."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/imm.13417","article-title":"Prostaglandin E2 Directly Inhibits the Conversion of Inducible Regulatory T Cells through EP2 and EP4 Receptors via Antagonizing TGF-\u03b2 Signalling","volume":"164","author":"Goepp","year":"2021","journal-title":"Immunology"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"eabd7954","DOI":"10.1126\/sciadv.abd7954","article-title":"Prostaglandin E2 Promotes Intestinal Inflammation via Inhibiting Microbiota-Dependent Regulatory T Cells","volume":"7","author":"Crittenden","year":"2021","journal-title":"Sci. Adv."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"16039","DOI":"10.1038\/nrdp.2016.39","article-title":"Systemic Lupus Erythematosus","volume":"2","author":"Kaul","year":"2016","journal-title":"Nat. Rev. Dis. Primer"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Yap, D.Y.H., and Chan, T.M. (2019). B Cell Abnormalities in Systemic Lupus Erythematosus and Lupus Nephritis\u2014Role in Pathogenesis and Effect of Immunosuppressive Treatments. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20246231"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/art.40396","article-title":"Review: Abnormal B Cell Development in Systemic Lupus Erythematosus: What the Genetics Tell Us","volume":"70","author":"Karrar","year":"2018","journal-title":"Arthritis Rheumatol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.biocel.2009.10.011","article-title":"The Role of B Cells in Lupus Pathogenesis","volume":"42","author":"Nashi","year":"2010","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1365-2567.2009.03152.x","article-title":"Inhibition of Cyclooxygenase-2 Impairs the Expression of Essential Plasma Cell Transcription Factors and Human B-lymphocyte Differentiation","volume":"129","author":"Bernard","year":"2010","journal-title":"Immunology"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"6736","DOI":"10.4049\/jimmunol.176.11.6736","article-title":"APRIL and BAFF Promote Increased Viability of Replicating Human B2 Cells via Mechanism Involving Cyclooxygenase 2","volume":"176","author":"Mongini","year":"2006","journal-title":"J. Immunol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1002\/(SICI)1521-4141(199911)29:11<3793::AID-IMMU3793>3.0.CO;2-3","article-title":"Biphenotypic B \/ Macrophage Cells Express COX-1 and up-Regulate COX-2 Expression and Prostaglandin E2 Production in Response to pro-Inflammatory Signals","volume":"29","author":"Graf","year":"1999","journal-title":"Eur. J. Immunol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"9727","DOI":"10.1073\/pnas.0803644105","article-title":"Autoreactive IgG Memory Antibodies in Patients with Systemic Lupus Erythematosus Arise from Nonreactive and Polyreactive Precursors","volume":"105","author":"Mietzner","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Qiu, W., Yu, T., and Deng, G.-M. (2022). The Role of Organ-Deposited IgG in the Pathogenesis of Multi-Organ and Tissue Damage in Systemic Lupus Erythematosus. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.924766"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.clim.2017.09.013","article-title":"Depressed Serum IgM Levels in SLE Are Restricted to Defined Subgroups","volume":"183","author":"Hardt","year":"2017","journal-title":"Clin. Immunol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s12016-007-8046-x","article-title":"IgM Antibodies Against dsDNA in SLE","volume":"34","author":"Witte","year":"2008","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Luo, Y., and Zheng, S.G. (2016). Hall of Fame among Pro-Inflammatory Cytokines: Interleukin-6 Gene and Its Transcriptional Regulation Mechanisms. Front. Immunol., 7.","DOI":"10.3389\/fimmu.2016.00604"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s10875-007-9104-0","article-title":"Cytokine IL-6 and IL-10 as Biomarkers in Systemic Lupus Erythematosus","volume":"27","author":"Chun","year":"2007","journal-title":"J. Clin. Immunol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1191\/0961203304lu1023oa","article-title":"Rationale for Interleukin-6 Blockade in Systemic Lupus Erythematosus","volume":"13","author":"Tackey","year":"2004","journal-title":"Lupus"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.4049\/jimmunol.169.4.2148","article-title":"IL-10 Regulates Murine Lupus","volume":"169","author":"Yin","year":"2002","journal-title":"J. Immunol."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Biswas, S., Bieber, K., and Manz, R.A. (2022). IL-10 Revisited in Systemic Lupus Erythematosus. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.970906"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/art.1780390305","article-title":"Disease Severity in Patients with Systemic Lupus Erythematosus Correlates with an Increased Ratio of Interleukin-10: Interferon-\u03b3\u2013Secreting Cells in the Peripheral Blood","volume":"39","author":"Hagiwara","year":"1996","journal-title":"Arthritis Rheum."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1046\/j.1365-2249.2000.01369.x","article-title":"Increased Interferon-Gamma (IFN-\u03b3), IL-10 and Decreased IL-4 mRNA Expression in Peripheral Blood Mononuclear Cells (PBMC) from Patients with Systemic Lupus Erythematosus (SLE)","volume":"122","author":"Nagy","year":"2001","journal-title":"Clin. Exp. Immunol."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Liu, W., Zhang, S., and Wang, J. (2022). IFN-\u03b3, Should Not Be Ignored in SLE. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.954706"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/cei.13566","article-title":"Variety of Endosomal TLRs and Interferons (IFN-\u03b1, IFN-\u03b2, IFN-\u03b3) Expression Profiles in Patients with SLE, SSc and MCTD","volume":"204","author":"Wajda","year":"2021","journal-title":"Clin. Exp. Immunol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s12272-001-1185-6","article-title":"Prostaglandin E2-Mediated Dysregulation of Proinflammatory Cytokine Production in Pristane-Induced Lupus Mice","volume":"31","author":"Chae","year":"2008","journal-title":"Arch. Pharm. Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"4885","DOI":"10.1073\/pnas.93.10.4885","article-title":"Elevated Interleukin 6 Is Induced by Prostaglandin E2 in a Murine Model of Inflammation: Possible Role of Cyclooxygenase-2","volume":"93","author":"Hinson","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1089\/107999000312423","article-title":"Regulation of Macrophage Interleukin-6 (IL-6) and IL-10 Expression by Prostaglandin E2: The Role of P38 Mitogen-Activated Protein Kinase","volume":"20","author":"Williams","year":"2000","journal-title":"J. Interferon Cytokine Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/sj.bjp.0704705","article-title":"Regulation by PGE2 of the Production of Interleukin-6, Macrophage Colony Stimulating Factor, and Vascular Endothelial Growth Factor in Human Synovial Fibroblasts","volume":"136","author":"Inoue","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Amorim, N.R.T., Souza-Almeida, G., Luna-Gomes, T., Bozza, P.T., Canetti, C., Diaz, B.L., Maya-Monteiro, C.M., and Bandeira-Melo, C. (2020). Leptin Elicits In Vivo Eosinophil Migration and Activation: Key Role of Mast Cell-Derived PGD2. Front. Endocrinol., 11.","DOI":"10.3389\/fendo.2020.572113"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"6531","DOI":"10.4049\/jimmunol.175.10.6531","article-title":"Prostaglandin D2 Causes Preferential Induction of Proinflammatory Th2 Cytokine Production through an Action on Chemoattractant Receptor-Like Molecule Expressed on Th2 Cells","volume":"175","author":"Xue","year":"2005","journal-title":"J. Immunol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s12931-018-0893-x","article-title":"The Prostaglandin D2 Receptor 2 Pathway in Asthma: A Key Player in Airway Inflammation","volume":"19","author":"Domingo","year":"2018","journal-title":"Respir. Res."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/s41467-018-03129-8","article-title":"Prostaglandin D2 Amplifies Lupus Disease through Basophil Accumulation in Lymphoid Organs","volume":"9","author":"Pellefigues","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nm.2159","article-title":"Basophils and the T Helper 2 Environment Can Promote the Development of Lupus Nephritis","volume":"16","author":"Charles","year":"2010","journal-title":"Nat. Med."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1084\/jem.20140066","article-title":"Immunoglobulin E Plays an Immunoregulatory Role in Lupus","volume":"211","author":"Dema","year":"2014","journal-title":"J. Exp. Med."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/cmi.2016.47","article-title":"Contribution and Underlying Mechanisms of CXCR4 Overexpression in Patients with Systemic Lupus Erythematosus","volume":"14","author":"Zhao","year":"2017","journal-title":"Cell. Mol. Immunol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1161\/01.ATV.0000156482.76228.d1","article-title":"15-Deoxy-\u039412,14 -Prostaglandin J2 (15d-PGJ2) Signals Through Retinoic Acid Receptor\u2013Related Orphan Receptor-\u03b1 but Not Peroxisome Proliferator\u2013Activated Receptor-\u03b3 in Human Vascular Endothelial Cells: The Effect of 15d-PGJ2 on Tumor Necrosis Factor-\u03b1\u2013Induced Gene Expression","volume":"25","author":"Migita","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.4049\/jimmunol.164.3.1498","article-title":"Inhibition of Mesangial Cell Nitric Oxide in MRL\/ Lpr Mice by Prostaglandin J2 and Proliferator Activation Receptor-\u03b3 Agonists","volume":"164","author":"Reilly","year":"2000","journal-title":"J. Immunol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1006\/clim.2000.4985","article-title":"Prostaglandin J2 Inhibition of Mesangial Cell iNOS Expression","volume":"98","author":"Reilly","year":"2001","journal-title":"Clin. Immunol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s10059-012-2297-y","article-title":"The Nuclear Receptor PPARs as Important Regulators of T-Cell Functions and Autoimmune Diseases","volume":"33","author":"Choi","year":"2012","journal-title":"Mol. Cells"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1084\/jem.20082771","article-title":"The Nuclear Receptor PPAR\u03b3 Selectively Inhibits Th17 Differentiation in a T Cell\u2013Intrinsic Fashion and Suppresses CNS Autoimmunity","volume":"206","author":"Klotz","year":"2009","journal-title":"J. Exp. Med."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/sj.gene.6363832","article-title":"Peroxisome Proliferator-Activated Receptor-Gamma Agonists Inhibit Experimental Allergic Encephalomyelitis by Blocking IL-12 Production, IL-12 Signaling and Th1 Differentiation","volume":"3","author":"Natarajan","year":"2002","journal-title":"Genes Immun."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12964-022-00849-9","article-title":"The Activation of PPAR\u03b3 Enhances Treg Responses through Up-Regulating CD36\/CPT1-Mediated Fatty Acid Oxidation and Subsequent N-Glycan Branching of T\u03b2RII\/IL-2R\u03b1","volume":"20","author":"Miao","year":"2022","journal-title":"Cell Commun. Signal."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1006\/clim.2001.5181","article-title":"Human B Lymphocytes and B Lymphomas Express PPAR-\u03b3 and Are Killed by PPAR-\u03b3 Agonists","volume":"103","author":"Padilla","year":"2002","journal-title":"Clin. Immunol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1172\/JCI13202","article-title":"Peroxisome Proliferator-Activated Receptor-\u03b3 Haploinsufficiency Enhances B Cell Proliferative Responses and Exacerbates Experimentally Induced Arthritis","volume":"108","author":"Setoguchi","year":"2001","journal-title":"J. Clin. Investig."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1182\/blood-2004-12-4709","article-title":"PPAR-\u03b3 Agonists Inhibit Toll-like Receptor-Mediated Activation of Dendritic Cells via the MAP Kinase and NF-\u03baB Pathways","volume":"106","author":"Appel","year":"2005","journal-title":"Blood"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.4049\/jimmunol.169.3.1228","article-title":"Dendritic Cell Immunogenicity Is Regulated by Peroxisome Proliferator-Activated Receptor \u03b3","volume":"169","author":"Nencioni","year":"2002","journal-title":"J. Immunol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/34178","article-title":"The Peroxisome Proliferator-Activated Receptor-\u03b3 Is a Negative Regulator of Macrophage Activation","volume":"391","author":"Ricote","year":"1998","journal-title":"Nature"},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Kapadia, R. (2008). Mechanisms of Anti-Inflammatory and Neuroprotective Actions of PPAR-Gamma Agonists. Front. Biosci., 13.","DOI":"10.2741\/2802"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"4844","DOI":"10.1073\/pnas.97.9.4844","article-title":"15-Deoxy-\u039412,14-Prostaglandin J2 Inhibits Multiple Steps in the NF-\u03baB Signaling Pathway","volume":"97","author":"Straus","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.prostaglandins.2005.08.001","article-title":"Captopril Effect on Prostaglandin E2, Thromboxane B2 and Proteinuria in Lupus Nephritis Patients","volume":"78","author":"Daza","year":"2005","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1546-0096-12-29","article-title":"Safety of Celecoxib and Nonselective Nonsteroidal Anti-Inflammatory Drugs in Juvenile Idiopathic Arthritis: Results of the Phase 4 Registry","volume":"12","author":"Sobel","year":"2014","journal-title":"Pediatr. Rheumatol."},{"key":"ref_90","unstructured":"GlaxoSmithKline (2026, May 26). COX-2 Inhibitor Study in Patients with Rheumatoid Arthritis: A Phase III, 12-Week, Multicentre, Double-Blind, Randomised, Placebo- and Active Comparator-Controlled, Parallel Group Study to Investigate the Efficacy and Safety of GW406381, 5 mg, 10 mg, 25 mg, and 50 mg Administered Orally Once Daily in Adults with Rheumatoid Arthritis, Available online: https:\/\/clinicaltrials.gov\/study\/NCT00113308."},{"key":"ref_91","first-page":"526","article-title":"Omega-3 Fatty Acids, Inflammatory Status and Biochemical Markers of Patients with Systemic Lupus Erythematosus: A Pilot Study","volume":"57","author":"Lanna","year":"2017","journal-title":"Rev. Bras. Reumatol. Engl. Ed."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/11\/4921\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T12:53:20Z","timestamp":1780404800000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/11\/4921"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":91,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["ijms27114921"],"URL":"https:\/\/doi.org\/10.3390\/ijms27114921","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]}}}